消化器内科 論文(2022年)
英語論文
| 著者 | タイトル | ジャーナル |
| Tomoya Yokota. | Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer. | Case Rep Oncol |
| Tomoya Yokota, Takao Ueno, Yoshihiko Soga, Hiroto Ishiki, Yasuhito Uezono, Takehiko Mori, Sadamoto Zenda, Yosuke Uchitomi | J-SUPPORT research policy for oral mucositis associated with cancer treatment. | Cancer Med. |
| Tsushima T. | New Neoadjuvant and Adjuvant Strategies for Advanced Esophageal Cancer. | Gan To Kagaku Ryoho. |
| Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Akifumi Notsu, Fuyuki Sato, Takeshi Kawakami, Hirofumi Ogawa, Tsuyoshi Onoe, Takashi Mukaigawa | Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer. | BMC Cancer. |
| Kawakami T, Masuishi T, Kawamoto Y, Go H, Kato K, Kumanishi R, Sawada K, Yuki S, Yamamoto K, Komatsu Y, Muro K, Fushiki K, Shirasu H, Yamazaki K. | The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study | Cancer Med. |
| Kawakami T, Mizusawa J, Hasegawa H, Imazeki H, Kano K, Sato Y, Iwasa S, Takiguchi S, Kurokawa Y, Doki Y, Boku N, Yoshikawa T, Terashima M. | Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001) | Gastric Cancer. |
| Yamazaki K, Kawakami T, Shirasu H, Fushiki K, Murase M, Murakami H. | [Treatment Strategy with Immune Checkpoint Inhibitors and Genetic Testing for Colorectal Cancer with Microsatellite Instability-High] | Gan To Kagaku Ryoho. |
| Shimozaki K, Hirata K, Sato T, Nakamura M, Kato K, Hirano H, Kumekawa Y, Hino K, Kawakami K, Kito Y, Matsumoto T, Kawakami T, Komoda M, Nagashima K, Sato Y, Yamazaki K, Hironaka S, Takaishi H, Hamamoto Y, Muro K. | WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study). | Clin Colorectal Cancer. |
| Shimoda Y, Nagashima T, Urakami K, Kamada F, Nakatani S, Mizuguchi M, Serizawa M, Hatakeyama K, Ohshima K, Mochizuki T, Ohnami S, Ohnami S, Kawakami T, Yamazaki K, Murakami H, Kenmotsu H, Shiomi A, Akiyama Y, Yamaguchi K. | Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients. | Biomed Res. |
| Sato J, Ishikawa H, Hamauchi S, Yamawaki Y, Mori K, Kiyohara Y, Yoshikawa S, Yamazaki K, Yasui H, Shino M. | Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reaction. | J Oncol Pharm Pract. |
| Sakai SA, Aoshima M, Sawada K, Horasawa S, Yoshikawa A, Fujisawa T, Kadowaki S, Denda T, Matsuhashi N, Yasui H, Goto M, Yamazaki K, Komatsu Y, Nakanishi R, Nakamura Y, Bando H, Hamaya Y, Kageyama SI, Yoshino T, Tsuchihara K, Yamashita R. | Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities. | Front Cell Infect Microbiol. |
| Ohwada S, Todaka A, Nakase H, Shirasu H, Kawakami T, Hamauchi S, Tsushima T, Yokota T, Onozawa Y, Yasui H, Yamazaki K. | Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study. | Invest New Drugs. |
| Nakamura Y, Okamoto W, Denda T, Nishina T, Komatsu Y, Yuki S, Yasui H, Esaki T, Sunakawa Y, Ueno M, Shinozaki E, Matsuhashi N, Ohta T, Kato K, Ohtsubo K, Bando H, Hara H, Satoh T, Yamazaki K, Yamamoto Y, Okano N, Terazawa T, Kato T, Oki E, Tsuji A, Horita Y, Hamamoto Y, Kawazoe A, Nakajima H, Nomura S, Mitani R, Yuasa M, Akagi K, Yoshino T. | Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy. | JCO Precis Oncol. |
| Mizuno D, Kawahara M, Konoha-Mizuno K, Yamazaki K. | Enhancing Cytotoxicity of Tamoxifen Using Geranium Oil | Evid Based Complement Alternat Med. |
| Miyo M, Kato T, Nakamura Y, Taniguchi H, Takahashi Y, Ishii M, Okita K, Ando K, Yukami H, Mishima S, Yamazaki K, Kotaka M, Watanabe J, Oba K, Aleshin A, Billings PR, Rabinowitz M, Kotani D, Oki E, Takemasa I, Mori M, Yoshino T. | DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy. | Cancer Sci. |
| Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. | ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence. | Ann Surg Oncol. |
| Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. | The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. | Ann Surg Oncol. |
| Bando H, Nakamura Y, Taniguchi H, Shiozawa M, Yasui H, Esaki T, Kagawa Y, Denda T, Satoh T, Yamazaki K, Sunakawa Y, Kato T, Goto M, Yuki S, Nishina T, Oki E, Shinozaki E, Matsuhashi N, Takahashi N, Tsuji A, Ohtsubo K, Wakabayashi M, Ikeno T, Hata M, Odegaard JI, Yoshino T. | Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer | JCO Precis Oncol |
| Kataoka K, Yamada T, Taniguchi H, Ikeda M, Yamazaki K, Kanemitsu Y. | A ctDNA-driven multidisciplinary treatment strategy for resectable colorectal cancer -what surgical oncologists should know | Eur J Surg Oncol |
| Shimoda Y, Nagashima T, Urakami K, Kamada F, Nakatani S, Mizuguchi M, Serizawa M, Hatakeyama K, Ohshima K, Mochizuki T, Ohnami S, Ohnami S, Kawakami T, Yamazaki K, Murakami H, Kenmotsu H, Shiomi A, Akiyama Y, Yamaguchi K. | Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients | Biomed Res |
| Kajiwara T, Nishina T, Nakasya A, Yamashita N, Yamashita R, Nakamura Y, Shiozawa M, Yuki S, Taniguchi H, Hara H, Ohta T, Esaki T, Shinozaki E, Takashima A, Moriwaki T, Denda T, Ohtsubo K, Sunakawa Y, Horita Y, Kawakami H, Kato T, Satoh T, Ando K, Mizutani T, Yasui H, Goto M, Okuyama H, Yamazaki K, Yoshino T, Hyodo I. | NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN) | J Cancer Res Clin Oncol |
| Ito T, Takashima A, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Moriwaki T, Sugimoto N, Ojima H, Takii Y, Yasui H, Esaki T, Tsuji A, Goto M, Saruta M, Otsu S, Shinozaki K, Fujiwara T, Tamura T, Baba E, Shiozawa M, Denda T, Ueno H, Nagashima K, Shimada Y. | Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum | Int J Clin Oncol |
| Hino K, Nishina T, Kajiwara T, Bando H, Nakamura M, Kadowaki S, Minashi K, Yuki S, Ohta T, Hara H, Mizukami T, Moriwaki T, Ohtsubo K, Komoda M, Mitani S, Nagashima F, Kato K, Yamada T, Hasegawa H, Yamazaki K, Yoshino T, Hyodo I. | Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric and Gastric Cancer | JCO Precis Oncol |
| Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. | The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion | Ann Surg Oncol |
| Matsubayashi H, Higashigawa S, Kiyozumi Y, Oishi T, Sasaki K, Ishiwatari H, Imai K, Hotta K, Yabuuchi Y, Ishikawa K, Satoh T, Ono H, Todaka A, Kawakami T, Shirasu H, Yasui H, Sugiura T, Uesaka K, Kagawa H, Shiomi A, Kado N, Hirashima Y, Kiyohara Y, Bando E, Niwakawa M, Nishimura S, Aramaki T, Mamesaya N, Kenmotsu H, Horiuchi Y, Serizawa M. | Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses | BMC Cancer |
| Higashigawa S, Matsubayashi H, Kiyozumi Y, Kado N, Nishimura S, Oishi T, Sugino T, Fushiki K, Shirasu H, Yasui H, Mamesaya N, Fukuzaki N, Kunitomo K, Horiuchi Y, Kenmotsu H, Serizawa M. | Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system | Jpn J Clin Oncol |
| Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, Mitani H, Iwae S, Fujimoto Y, Onozawa Y, Hanai N, Ogawa T, Hara H, Monden N, Shimura E, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Ota I, Shiga K, Sugasawa M, Asakage T, Saito Y, Murono S, Nishimura Y, Nakamura K, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). | Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial | J Clin Oncol |
| Yasui K, Kondou R, Miyata H, Iizuka A, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Muramatsu K, Sugino T, Yamaguchi K, Ogawa H, Onoe T, Harada H, Asakura H, Murayama S, Nishimura T, Goto S, Okada S, Mukaigawa T, Hamauchi S, Yokota T, Onozawa Y, Akiyama Y. | Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence | Anticancer Res |
| Imamura Y, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Yokota T, Okano S, Tanaka K, Onoe T, Ariizumi Y, Homma A. | Systemic therapy for salivary gland malignancy: current status and future perspectives | Jpn J Clin Oncol |
| Saito Y, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Yokota T, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R. | Human papillomavirus-related oropharyngeal carcinoma | Jpn J Clin Oncol |
| Takahashi S, Oridate N, Tanaka K, Shimizu Y, Fujimoto Y, Matsumoto K, Yokota T, Yamazaki T, Takahashi M, Ueda T, Hanai N, Yamaguchi H, Hara H, Yoshizaki T, Yasumatsu R, Nakayama M, Shiga K, Fujii T, Mitsugi K, Takahashi K, Nohata N, Gumuscu B, Swaby RF, Tahara M. | First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048 | Int J Clin Oncol |
| Yasumatsu R, Shimizu Y, Hanai N, Kariya S, Yokota T, Fujii T, Tsukahara K, Ando M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Nekado T, Yamada T, Homma A. | Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study | Int J Clin Oncol |
| Ota Y, Kodaira T, Fujii H, Shimokawa M, Yokota T, Nakashima T, Monden N, Homma A, Ueda S, Akimoto T. | Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2) | Int J Clin Oncol |
| Yoshida Y, Kobayashi S, Ueno M, Morizane C, Tsuji K, Maruki Y, Mori K, Watanabe K, Ohba A, Furuta M, Todaka A, Tsujimoto A, Ozaka M, Okano N, Yane K, Umemoto K, Kawamoto Y, Terashima T, Tsumura H, Doi K, Shioji K, Asagi A, Kojima Y, Suzuki E, Toshiyama R, Furukawa M, Naganuma A, Suzuki R, Miwa H, Ikeda M, Furuse J. | Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis | Pancreatology |
| Miura Y, Ashida R, Sugiura T, Ohgi K, Yamada M, Otsuka S, Todaka A, Uesaka K. | Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report | Surg Case Rep |
| Kobayashi S, Suzuki M, Ueno M, Maruki Y, Okano N, Todaka A, Ozaka M, Tsuji K, Shioji K, Doi K, Kojima Y, Tsumura H, Tanaka K, Higuchi H, Kawabe K, Imaoka H, Yamashita T, Miwa H, Nagano H, Arima S, Hayashi H, Naganuma A, Yamaguchi H, Hisano T, Umemoto K, Ishii S, Nakashima K, Suzuki R, Kitano Y, Misumi T, Furuse J, Ishii H. | Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer | Oncologist |
| Yamada I, Morizane C, Okusaka T, Mizusawa J, Kataoka T, Ueno M, Ikeda M, Okano N, Todaka A, Shimizu S, Mizuno N, Sekimoto M, Tobimatsu K, Yamaguchi H, Nishina T, Shirakawa H, Kojima Y, Oono T, Kawamoto Y, Furukawa M, Iwai T, Sudo K, Okamura K, Yamashita T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; JCOG-HBPOG. | The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113 | Sci Rep |
| Tezuka K, Ohgi K, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Otsuka S, Todaka A, Uesaka K. | The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy | J Hepatobiliary Pancreat Sci |
| Takeuchi H, Ito Y, Machida R, Kato K, Onozawa M, Minashi K, Yano T, Nakamura K, Tsushima T, Hara H, Okuno T, Hironaka S, Nozaki I, Ura T, Chin K, Kojima T, Seki S, Sakanaka K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. | A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study) | Int J Radiat Oncol Biol Phys |
| Inoue T, Ishihara R, Shibata T, Suzuki K, Kitagawa Y, Miyazaki T, Yamaji T, Nemoto K, Oyama T, Muto M, Takeuchi H, Toh Y, Matsubara H, Mano M, Kono K, Kato K, Yoshida M, Kawakubo H, Booka E, Yamatsuji T, Kato H, Ito Y, Ishikawa H, Tsushima T, Kawachi H, Oyama T, Kojima T, Kuribayashi S, Makino T, Matsuda S, Doki Y; Esophageal Cancer Practice Guidelines Preparation Committee. | Endoscopic imaging modalities for diagnosing the invasion depth of superficial esophageal squamous cell carcinoma: a systematic review | Esophagus |
| Yamaguchi K, Minashi K, Sakai D, Nishina T, Omuro Y, Tsuda M, Iwagami S, Kawakami H, Esaki T, Sugimoto N, Oshima T, Kato K, Amagai K, Hosaka H, Komine K, Yasui H, Negoro Y, Ishido K, Tsushima T, Han S, Shiratori S, Takami T, Shitara K. | Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer | Cancer Sci |
| Sakai M, Kitagawa Y, Saeki H, Miyazaki T, Yamaji T, Nemoto K, Oyama T, Muto M, Takeuchi H, Toh Y, Matsubara H, Mano M, Kono K, Kato K, Yoshida M, Kawakubo H, Booka E, Yamatsuji T, Kato H, Ito Y, Ishikawa H, Ishihara R, Tsushima T, Kawachi H, Oyama T, Kojima T, Kuribayashi S, Makino T, Matsuda S, Sohda M, Kubo Y, Doki Y; Esophageal Cancer Practice Guidelines Preparation Committee. | Fruit and vegetable consumption and risk of esophageal cancer in the Asian region: a systematic review and meta-analysis | Esophagus |
| Matsuda S, Tsushima T, Kato K, Hsu CH, Lee JM, Wong IY, Wang HC, Kang CH, Guo X, Yamamoto S, Tsuji T, Kawakubo H, Takeuchi H, Law S, Kitagawa Y. | Defining conversion therapy for esophageal squamous cell carcinoma | Ann Gastroenterol Surg |
| Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Murakami K, Muro K, Numasaki H, Oyama T, Ozawa S, Saeki H, Tanaka K, Tsushima T, Ueno M, Uno T, Yoshio T, Usune S, Takahashi A, Miyata H; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. | Comprehensive registry of esophageal cancer in Japan, 2014 | Esophagus |
| Kubo Y, Kitagawa Y, Miyazaki T, Sohda M, Yamaji T, Sakai M, Saeki H, Nemoto K, Oyama T, Muto M, Takeuchi H, Toh Y, Matsubara H, Mano M, Kono K, Kato K, Yoshida M, Kawakubo H, Booka E, Yamatsuji T, Kato H, Ito Y, Ishikawa H, Ishihara R, Tsushima T, Kawachi H, Oyama T, Kojima T, Kuribayashi S, Makino T, Matsuda S, Doki Y; Esophageal Cancer Practice Guidelines Preparation Committee. | The potential for reducing alcohol consumption to prevent esophageal cancer morbidity in Asian heavy drinkers: a systematic review and meta-analysis | Esophagus |
| Mori Y, Kikuchi O, Horimatsu T, Hara H, Hironaka S, Kojima T, Kato K, Tsushima T, Ishihara R, Mukai K, Uozumi R, Tada H, Kasai H, Kawaguchi A, Muto M. | Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study | Esophagus |
和文論文
| 著者 | タイトル | ジャーナル | |
| 安井博史、小野澤祐輔 | 静がんメソッド 消化器癌編 第3版 | 日本医事新報社 | |
| 津軽 開, 山崎 健太郎 | 【新しいがん治療のState of the Art】臓器別 切除不能進行再発大腸がんの分子標的治療の現状と展望 | がん分子標的治療 | (1347-6955)20巻1号 Page44-48 |
| 横田 知哉 | 臓器別がん 最新エビデンスに基づいた薬物療法と看護の実践 頭頸部がん | がん看護 | (1342-0569)27巻6号 Page615-621 |
| 對馬 隆浩 | Upper G.I.Cancer 食道・胃癌 食道癌に対する補助療法の新展開 | 癌と化学療法 | (0385-0684)49巻9号 Page938-941 |
| 山崎 健太郎, 川上 武志, 白数 洋充, 伏木 邦博, 村瀬 真貴, 村上 裕美 | 高頻度マイクロサテライト不安定性大腸癌に対する免疫チェックポイント阻害薬による治療戦略と遺伝子検査の概要 | 癌と化学療法 | (0385-0684)49巻7号 Page761-767 |
| 西村 在、横田 知哉 | 【高齢者の頭頸部癌治療-ポイントと治療後のフォローアップ-】免疫療法 | ENTONI | (1346-2067)272号 Page15-19 |
| 西村 在、山﨑 健太郎 | 【直腸癌局所再発に挑む-最新の治療戦略と手術手技】総論 直腸癌局所再発に対する薬物療法 | 臨床外科 | (0386-9857)77巻5号 Page520-523 |
| 大嶋 琴絵、朴 成和 | 【お薬立ちBOOK2022 解剖生理・病態生理から薬学管理へ】病態生理を踏まえた薬物治療・薬学管理へ がん・支持療法 大腸癌 | 薬局 | (0044-0035)73巻4号 Page1436-1444 |
| 大嶋 琴絵、朴 成和 | 【お薬立ちBOOK2022 解剖生理・病態生理から薬学管理へ】病態生理を踏まえた薬物治療・薬学管理へ がん・支持療法 胃癌 | 薬局 | (0044-0035)73巻4号 Page1428-1432 |
| 白数 洋充、山﨑 健太郎 | 【大腸癌化学療法を学ぶ】大腸癌におけるバイオマーカーの現状と問題点 | (2432-3446)11巻3号 Page265-271 | |
| 白数 洋充、山﨑 健太郎 | BRAF & KRASG12C阻害薬 なぜ大腸がんに効果が乏しい? | がん分子標的治療 | (1347-6955)19巻2号 Page232-236 |